Image may be NSFW.
Clik here to view.
Clik here to view.
Isotechnika gets more funding for NICAM program
Isotechnika Pharma (TSX: ISA) has received additional funding from the National Research Council Industrial Research Assistance Program (NRC-IRAP) for its non-immunosuppressive cyclophilin antagonist...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Ciclofilin to present HIV/HCV co-infection results at AASLD
Closely held Ciclofilin Pharmaceuticals will present an abstract about its lead drug candidate, CPI-432-32, at the liver meeting of the annual meeting of the American Association for the Study of Liver...
View Article
More Pages to Explore .....
